NFJ Investment Group LLC Invests $2.68 Million in Aveanna Healthcare Holdings Inc. $AVAH

NFJ Investment Group LLC bought a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 312,997 shares of the company’s stock, valued at approximately $2,682,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd increased its stake in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Aveanna Healthcare during the 1st quarter worth approximately $53,000. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Entropy Technologies LP acquired a new position in shares of Aveanna Healthcare in the 3rd quarter valued at $107,000. Finally, Oxford Asset Management LLP acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at $64,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Aveanna Healthcare

In related news, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the transaction, the insider owned 252,899 shares of the company’s stock, valued at $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Paul R. Vigano sold 7,000,000 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the transaction, the insider owned 252,899 shares in the company, valued at $1,578,089.76. This trade represents a 96.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 31,180,664 shares of company stock worth $214,607,160. 5.30% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on AVAH shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Truist Financial boosted their price target on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. UBS Group upped their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Finally, Barclays lifted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $11.78.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $12.97 on Friday. The company’s 50 day simple moving average is $9.46 and its 200-day simple moving average is $7.88. The firm has a market cap of $2.83 billion, a PE ratio of 10.54, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.40. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, equities analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.